BAA contract entitled "master data management informatics analysis for the center for drug evaluation and research"
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40120C00154
- Awardee
-
Lumendata, Inc. UEI ZYWKWTMMDD15
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $4,816,915
Award facts
- Opportunity
-
- Food and Drug Administration Broad Agency Announcement (BAA) for the Advanced Research and Development of Regulatory Science - Amendment 2 Solicitation · FDABAA2000123 · Posted Sep 27, 2019
- Contract value 100% obligated
- $4,816,915.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541511 Custom Computer Programming Services
- PSC
- AJ22 R&D- General Sci/Tech: Mathematical/Computer Sciences (Applied Research/Exploratory Development)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 12 offers Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Santa Clara, CA 95054, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$238,719 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,871,339 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,121,300 | |
| Original award | $1,062,995 |
About this award
Lumendata Inc., a minority-owned small business, was awarded a $4.8 million firm fixed-price definitive contract by the Food and Drug Administration (FDA) on September 28, 2020, to provide Master Data Management Informatics Analysis services for the Center for Drug Evaluation and Research. The contract, which concluded on September 27, 2023, was awarded without a set-aside designation through a Broad Agency Announcement focused on advancing regulatory science and innovation across the FDA's key research areas. Performance was conducted in Santa Clara, California, with services encompassing data analytics, informatics analysis, data governance, data integration, and enterprise data management solutions designed to enhance the FDA's capabilities in evaluating medical products and protecting public health.
The underlying BAA solicitation, posted in September 2019, sought advanced research and development proposals to support regulatory science initiatives within the physical, engineering, and life sciences sectors. The FDA's evaluation criteria emphasized technical merit, offeror qualifications, and cost reasonableness, with the agency anticipating multiple awards of indefinite quantities through this annually renewed instrument. Lumendata's selection under this opportunity reflects the company's specialized expertise in master data management and informatics services, positioning the FDA's Center for Drug Evaluation and Research to leverage enhanced data analytics capabilities in support of its regulatory mission.
Quick answers
Who was awarded contract 75F40120C00154?
75F40120C00154 was awarded to Lumendata, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 28, 2020.
How much is contract 75F40120C00154 worth?
The government has obligated $4,816,915 on 75F40120C00154.
Was contract 75F40120C00154 competed?
The extent of competition for 75F40120C00154 was full and open competition. The government received 12 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award